Timestamps:
0:00 Intro
00:51 Could you give us an update about what has been happening regarding convalescent plasma?
03:46 What are some take-home points from this new AABB guidelines that are out?
15:07 Were there challenges discussed or things that you see these guidelines either domestically or internationally? 
18:20 Is there an aspect that you would like to see addressed with more robust data as we go forward?
20:12 Outro

Resources:
AABB Guidelines